about
Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI StudyThe risk of large for gestational age across increasing categories of pregnancy glycemia.Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.Metformin use and lung cancer risk in patients with diabetes.Pregnancy glucose levels in women without diabetes or gestational diabetes and childhood cardiometabolic risk at 7 years of ageChange in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy.Outreach to diversify clinical trial participation: A randomized recruitment studySex ratio variations among the offspring of women with diabetes in pregnancy.The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial.Pregnancy glycemia in Mexican-American women without diabetes or gestational diabetes and programming for childhood obesity.Lifestyle behaviors and ethnic identity among diverse women at high risk for type 2 diabetesModerate and Vigorous Intensity Exercise During Pregnancy and Gestational Weight Gain in Women with Gestational Diabetes.Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus.Risk of large-for-gestational-age newborns in women with gestational diabetes by race and ethnicity and body mass index categoriesMaternal gestational weight gain and offspring risk for childhood overweight or obesity.A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study.Strategies for diabetes prevention before and after pregnancy in women with GDM.A Population Health Driver Diagram to Address Neonatal Abstinence Syndrome.Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014.Protective role of physical activity on type 2 diabetes: Analysis of effect modification by race-ethnicity.Moderate intensity sports and exercise is associated with glycaemic control in women with gestational diabetes.Migrant Latino day laborers and intentions to test for HIV.Erratum to: Moderate and Vigorous Intensity Exercise During Pregnancy and Gestational Weight Gain in Women with Gestational Diabetes.Neonatal Abstinence Syndrome in East Tennessee: Characteristics and Risk Factors among Mothers and Infants in One Area of Appalachia.A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational DiabetesDietary Quality and Glycemic Control Among Women with Gestational Diabetes MellitusDiagnostic thresholds for pregnancy hyperglycemia, maternal weight status and the risk of childhood obesity in a diverse Northern California cohort using health care delivery system dataGestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesityA Tailored Letter Based on Electronic Health Record Data Improves Gestational Weight Gain Among Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster-Randomized Controlled Trial
P50
Q33556884-33260D65-F367-41F4-B067-8475554B60A9Q33784564-3E736B08-4503-4F85-9B6C-5AC1069D5518Q34645317-9E0F4C67-19F1-4F4F-A07D-0841B1DC7528Q34671802-7A5753F4-8B46-4E4F-B2F6-C0355FDAA369Q35046673-9AADADFF-E285-428C-A119-EAFC5F99CB9AQ35500323-BF625C98-6AE9-4677-ABAC-F1BB58DF0AD6Q35568948-F5453E58-B960-4F63-8355-F98986039559Q35582304-C5E95471-3132-4F39-837C-8329D4753C33Q36084025-24399DA0-02F2-44A6-93E5-8E73962C2865Q36392569-BDF10B92-E0E1-4DC3-8B4A-8D094EBED981Q36889504-AC244042-4F5F-42D1-AA62-77CC27189013Q37016556-3ECF8AF7-A675-4CE0-B0E7-768FCDF44A2DQ37248353-0FCB5665-A657-4EBC-93DD-47AFE772F723Q37331309-3F0A8367-E78F-4C26-8CE3-69ED80881C4CQ37364730-3EA1F228-B124-4B16-A3F4-B0C2502956B1Q37375094-BE12960A-33C8-4570-8D77-E10966C08FCDQ37501285-11322C80-01AA-4976-B7AD-086A6CD86E79Q37827525-39CE9BA4-C642-4626-9203-668483934B5CQ38970031-C4A3DC51-CF59-465A-89A5-A8FD8114E759Q39280391-3D93B706-96DD-4D75-ADFB-24745E0BB320Q39330066-21307E4D-3F62-4B48-A7C0-44B9B2878032Q40317924-144C81D1-AF43-41E3-837E-6CD4DB63F989Q43804357-710AB40A-2515-4960-B373-66B48FE7361EQ46122910-54FA0EB5-A386-447D-95E2-A71B5EBC0D27Q47412890-3EAD2A77-2034-42E7-88AA-0DEB7A8569B2Q57300406-82158390-247F-4A81-8214-749958A6B4AFQ58096895-6EA4109D-6A38-4ACA-83B3-65BEDEA9A778Q64058482-550CF591-642E-43EC-8926-EFF47C5345F8Q64077846-23C52AD3-18FA-4255-800F-A9315EFFE6AEQ88400597-94182E31-5D65-449D-968C-CFAB89E2FF37
P50
description
researcher ORCID ID = 0000-0002-0074-8399
@en
wetenschapper
@nl
name
Samantha F Ehrlich
@ast
Samantha F Ehrlich
@en
Samantha F Ehrlich
@es
Samantha F Ehrlich
@nl
type
label
Samantha F Ehrlich
@ast
Samantha F Ehrlich
@en
Samantha F Ehrlich
@es
Samantha F Ehrlich
@nl
prefLabel
Samantha F Ehrlich
@ast
Samantha F Ehrlich
@en
Samantha F Ehrlich
@es
Samantha F Ehrlich
@nl
P1153
35307105000
P21
P31
P496
0000-0002-0074-8399